These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33214256)

  • 41. Digital PCR is a sensitive new technique for SARS-CoV-2 detection in clinical applications.
    Jiang Y; Wang H; Hao S; Chen Y; He J; Liu Y; Chen L; Yu Y; Hua S
    Clin Chim Acta; 2020 Dec; 511():346-351. PubMed ID: 33159953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2.
    Zhang Y; Dai C; Wang H; Gao Y; Li T; Fang Y; Shen Z; Chen L; Chen Z; Ma X; Li M
    Virol J; 2020 Dec; 17(1):197. PubMed ID: 33371898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What reinfections mean for COVID-19.
    Iwasaki A
    Lancet Infect Dis; 2021 Jan; 21(1):3-5. PubMed ID: 33058796
    [No Abstract]   [Full Text] [Related]  

  • 44. How has the COVID-19 pandemic impacted PCR?
    Martin J
    Biotechniques; 2020 Dec; 69(6):404-405. PubMed ID: 33222515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positive control synthesis method for COVID-19 diagnosis by one-step real-time RT-PCR.
    Cho H; Jung YH; Cho HB; Kim HT; Kim KS
    Clin Chim Acta; 2020 Dec; 511():149-153. PubMed ID: 33058837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 47. Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19.
    Smalley DL; Cisarik PM; Grantham J; Cloud W; Neil RB; DePriest P
    Lab Med; 2021 Jan; 52(1):e15-e16. PubMed ID: 33206195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Aug; 16(703):1530-1531. PubMed ID: 32852182
    [No Abstract]   [Full Text] [Related]  

  • 49. Experimental Infection of Cattle with SARS-CoV-2.
    Ulrich L; Wernike K; Hoffmann D; Mettenleiter TC; Beer M
    Emerg Infect Dis; 2020 Dec; 26(12):2979-2981. PubMed ID: 33034284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.
    Breathnach AS; Riley PA; Cotter MP; Houston AC; Habibi MS; Planche TD
    J Infect; 2021 Apr; 82(4):e11-e12. PubMed ID: 33450303
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Australia: Epidemiology Report 30: Fortnightly reporting period ending 22 November 2020.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Nov; 44():. PubMed ID: 33267752
    [No Abstract]   [Full Text] [Related]  

  • 52. Role of presymptomatic transmission of COVID-19: evidence from Beijing, China.
    Zhang Y; Muscatello D; Tian Y; Chen Y; Li S; Duan W; Ma C; Sun Y; Wu S; Ge L; Yang P; Jia L; Wang Q; MacIntyre CR
    J Epidemiol Community Health; 2021 Jan; 75(1):84-87. PubMed ID: 32855261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report.
    Torres DA; Ribeiro LDCB; Riello APFL; Horovitz DDG; Pinto LFR; Croda J
    J Med Virol; 2021 Apr; 93(4):1857-1859. PubMed ID: 33112002
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunity Acquired From the First Wave of COVID-19 Against Reinfections Up to Omicron Predominance.
    Lan FY; Kasteler SD; Sidossis A; Iliaki E; Buley J; Nathan N; Osgood R; Bruno-Murtha LA; Kales SN
    Mayo Clin Proc; 2023 Jan; 98(1):202-203. PubMed ID: 36603950
    [No Abstract]   [Full Text] [Related]  

  • 55. COVID-19: Are reinfections a global health threat?
    Banerjee I; Robinson J; Sathian B
    Nepal J Epidemiol; 2021 Mar; 11(1):933-936. PubMed ID: 33868739
    [No Abstract]   [Full Text] [Related]  

  • 56. SARS-CoV-2 reinfection and implications for vaccine development.
    Nainu F; Abidin RS; Bahar MA; Frediansyah A; Emran TB; Rabaan AA; Dhama K; Harapan H
    Hum Vaccin Immunother; 2020 Dec; 16(12):3061-3073. PubMed ID: 33393854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retraction.
    Sijen T; Steiner FA; Thijssen KL; Plasterk RHA
    Science; 2020 Nov; 370(6519):921. PubMed ID: 33214285
    [No Abstract]   [Full Text] [Related]  

  • 59. What the data say about asymptomatic COVID infections.
    Nogrady B
    Nature; 2020 Nov; 587(7835):534-535. PubMed ID: 33214725
    [No Abstract]   [Full Text] [Related]  

  • 60. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.